Eureka Home »
Welcome to Eureka, an online community for scientists to explore, connect and share big ideas.
The human brain contains 100 billion neurons—with 100 trillion connections. There is a lot we don't understand about how these networks of neurons process information, but advances in neuroimaging are helping us focus better.
About two decades ago, scientists isolated the gene defective in people with Huntington's disease, and jumpstarted research into this lethal neurodegenerative disorder. How far the field has progressed is a glass half-full, glass half-empty kind of question.
Rapid advances in powerful neuroimaging tools are allowing researchers to quantify deficits in CNS disease. This could bring us closer to effective treatments for Alzheimer's.
The Society for Neuroscience meeting, the world's largest gathering of neuroscientists, is a great opportunity to feast on the latest science. Here's what Eureka is eyeing on the menu.
The Ebola outbreak has been shining a very bright light on accelerated drug development. Charles River's resident FDA expert Lauren Black explains how the process works and why it's important.
There are a number of ways today in which the immune system is manipulated to keep cancer in check. But the idea of using the immune system to fight cancer is not new. In fact the roots of this strategy date back to the 1800s.
With so much hope riding on the development of vaccines against Ebola, it's important to remember that accelerating clinical evaluation carries risks as well as benefits.
Exhaust Air Dust Testing, a potential replacement for soiled bedding sentinels, is one of the hot topics at this year’s AALAS meeting.
A recent cancer symposium on new approaches in drug discovery reflects the paradigm shift in how we view this leading killer.
In a recent feature in GEN, Charles River’s Joseph Cornicelli and six other experts weigh in on what makes a good mouse model.